866-997-4948(US-Canada Toll Free)

PrevOnco Analysis and Market Forecasts from 2014 to 2020

Published By :

GlobalData

Published Date : Jul 2011

Category :

Therapeutic Area

No. of Pages : 27 Pages


GlobalDatas pharmaceuticals report, PrevOnco Analysis and Market Forecasts from 2014 to 2020 provides PrevOnco sales estimates for the US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Liver Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

Scope
  • Therapy area profile including patient population for the US and EU5
  • Analysis and review of PrevOnco including sales data
  • Qualitative and quantitative assessment of market space
  • Analysis of the trends, drivers and restraints shaping and defining the markets
  • In-depth analysis of PrevOnco including efficacy, safety, pricing and other details which influence its sales potential
  • Detailed sales forecast for 2014-2020 for PrevOnco in the US and EU5
Reasons to buy
  • Understand and capitalize by identifying products that are most likely to ensure a robust return
  • Stay ahead of competition by understanding the changing competitive landscape
  • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  • Make more informed business decisions from insightful and in-depth analysis of the drugs performance 
  • Examine the historical sales performance of a drug in seven major markets
  • Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Table of content

1 Table of contents
1 Table of contents 2
1.1 List of Tables 3
1.2 List of Figures 3

2 Introduction 4
2.1 Liver Cancer Market 4
2.2 Epidemiology 4
2.3 Etiology 5
2.3.1 Hepatitis B Infection 5
2.3.2 Hepatitis C Infection 5
2.3.3 Alcohol 5
2.3.4 Aflatoxin B1 6
2.3.5 Hemochromatosis 6
2.3.6 Diabetes and Obesity 6
2.3.7 Cirrhosis 6
2.4 GlobalData Report Guidance 6

3 Liver Cancer : Market Characterization 7
3.1 Liver Cancer Market 7
3.2 Liver Cancer Market Forecasts and CAGR 7
3.3 Drivers for the Liver Cancer Market 7
3.3.1 High Incidence 8
3.3.2 High Mortality 9
3.3.3 Large Unmet Need 9

4 TumorNodeMetastases (TNM) Classification of Liver Cancer 10

5 PrevOnco 11
5.1 Introduction 11
5.2 Mechanism of Action 11
5.3 Indications of PrevOnco 11
5.4 Factors Affecting Sales of PrevOnco 11
5.4.1 Both First Line and Second Line Treatments 11
5.4.2 NexACT NexMeds Drug Delivery Technology 11
5.4.3 Absence in Japan Market 12
5.4.4 Orphan Drug Status 12
5.5 Intensity of Competition 12
5.6 Sales Forecast 12
5.6.1 Target Patient Pool of PrevOnco 12
5.6.2 Dosing 13
5.6.3 Market Penetration 13
5.6.4 Annual Cost of Therapy 14
5.6.5 Sales Projections of PrevOnco 15

6 Liver Cancer Market: Appendix 23
6.1 Market Definitions 23
6.2 List of Abberiviations 23
6.3 Research Methodology 23
6.3.1 Coverage 23
6.3.2 Secondary Research 23
6.3.3 Forecasting 24
6.3.4 Number of Patients Approved to take the Drug 24
6.3.5 Net Penetration of Drug 25
6.3.6 Net Annual Dosing 25
6.3.7 Annual Cost of Therapy 25
6.3.8 Primary Research 25
6.3.9 Expert Panels 26
6.4 Drug Sales Estimates Model 26
6.5 Contact Us 27
6.6 Disclaimer 27
6.7 Sources 27

List of Table


Table 1: Liver Cancer, Incidences and Mortality, 20082030 4
Table 2: Annual Cost of Therapy 14
Table 3: PrevOnco, Liver Cancer, Global, Sales Forecasts ($m), 20142020 15
Table 4: PrevOnco, Liver Cancer, The US, Sales Forecasts ($m), 20142020 16
Table 5: PrevOnco, Liver Cancer, The UK, Sales Forecasts ($m), 20152020 17
Table 6: PrevOnco, Liver Cancer, France, Sales Forecasts ($m), 20152020 18
Table 7: PrevOnco, Liver Cancer, Germany, Sales Forecasts ($m), 20152020 19
Table 8: PrevOnco, Liver Cancer, Italy, Sales Forecasts ($m), 20152020 20
Table 9: PrevOnco, Liver Cancer, Spain, Sales Forecasts ($m), 20152020 21
Table 10: Drug Risk Benefit Score of Drug X 26

List of Chart


Figure 1: Fatality = [(% Distribution of Incidence) (% Distribution of Mortality)] of Most Common Cancers 5
Figure 2: Liver Cancer, Global, Market Size Forecast ($m), 20102020 7
Figure 3: Liver Cancer, Worldwide, Incidence (in millions), 20082030 8
Figure 4: Oncology, Worldwide, Incidence (in millions), 20082030 8
Figure 5: Liver Cancer, Worldwide, Mortality (in millions), 20082030 9
Figure 6: Classification of Liver Cancer 10
Figure 7: Drug Model Diagram of PrevOnco 13
Figure 8: PrevOnco, Liver Cancer, Global, Sales Forecasts ($m), 20142020 15
Figure 9: PrevOnco, Liver Cancer, The US, Sales Forecasts ($m), 20142020 16
Figure 10: PrevOnco, Liver Cancer, The UK, Sales Forecasts ($m), 20152020 17
Figure 11: PrevOnco, Liver Cancer, France, Sales Forecasts ($m), 20152020 18
Figure 12: PrevOnco, Liver Cancer, Germany, Sales Forecasts ($m), 20152020 19
Figure 13: PrevOnco, Liver Cancer, Italy, Sales Forecasts ($m), 20152020 20
Figure 14: PrevOnco, Liver Cancer, Spain, Sales Forecasts ($m), 20152020 21
Figure 15: PrevOnco, Liver Cancer, Global, Sales Distribution by Country (%), 2020 22
Figure 16: Drug Model Diagram 24
Figure 17: Patients Approved for the Drug 25

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *